YGX
LIVE

Serial Number

99105786

Owner

YGIX Medicines Limited

Attorney

Eryn Y. Truong

Filing Date

Mar 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

YGX Trademark

Serial Number: 99105786

YGX is a trademark filed by YGIX Medicines Limited on March 26, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently pending registration.

Owner Contact Info

YGIX Medicines Limited (2 trademarks)

Shankill Business Centre, Station House
Shankill, Dublin D18 N1N2 , IE

Entity Type: 99

Trademark Details

Filing Date

March 26, 2025

Registration Date

Not Registered

Published for Opposition

February 24, 2026

Goods & Services

Pharmaceutical research services; Pharmaceutical product evaluation; Research in the field of pharmaceuticals; Research relating to pharmaceuticals; Pharmaceutical research and development services; Research on the subject of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Research and development of new products for the pharmaceutical industry; Consultancy in the field of pharmaceutical research; Consultancy relating to pharmaceutical research and development; Laboratory research in the field of pharmaceuticals; Technical research in the field of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Providing scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical products development; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Consultancy in the field of biotechnology; Consultancy relating to biotechnology; Biotechnology testing; Biotechnology research; Research relating to biotechnology; Scientific research; Scientific testing services in the field of pharmaceuticals; Scientific research services; Scientific research consulting; Scientific laboratory services

Medical services in the nature of pharmaceutical consultation; Pharmaceutical advice; Pharmaceutical advisory services; Provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Intellectual property consultation; Intellectual property consultancy; Intellectual property licensing services; Management of intellectual property; Licensing of intellectual property; Licensing of intellectual property rights; Consultancy relating to intellectual property management; Intellectual property management services; Advisory services relating to intellectual property rights; Consultancy relating to the licensing of intellectual property; Intellectual property consultancy services for universities and research institutions

Pharmaceutical preparations for the treatment of oncological, hematological, immunological, neurological, cardiovascular, metabolic, infectious, inflammatory, dermatological, gastrointestinal, hepatic, respiratory, renal, ophthalmic, and musculoskeletal diseases and disorders in humans; Veterinary pharmaceutical preparations for the treatment of oncological, hematological, immunological, neurological, cardiovascular, metabolic, infectious, inflammatory, dermatological, gastrointestinal, hepatic, respiratory, renal, ophthalmic, and musculoskeletal diseases and disorders in animals

Filing History

TEAS POST PUBLICATION AMENDMENT RECEIVED
Apr 21, 2026 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 21, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 24, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 18, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 23, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 4, 2025 GNFN
FINAL REFUSAL E-MAILED
Nov 4, 2025 GNFR
FINAL REFUSAL WRITTEN
Nov 4, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 26, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 26, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 26, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 26, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 26, 2025 MAFR
NEW APPLICATION ENTERED
Mar 26, 2025 NWAP